iRhythm Reports Q3 2026 Revenue Growth Driven by Zio Monitor Demand
iRhythm (IRTC) reported strong third-quarter 2026 results, with revenue reaching $221.6 million, a 14.9% increase year-over-year. This growth was primarily fueled by robust demand for the core Zio Monitor business and expansion in international markets. The company also saw significant margin improvements, with gross margins rising to 74.2% due to manufacturing automation and operational efficiencies. Despite a GAAP net loss of $29.9 million caused by a one-time $50 million intellectual property litigation charge, adjusted net income rose to $27.8 million ($0.82 per diluted share). Management provided optimistic full-year guidance with revenue expected between $890 million and $895 million, supported by the recent acquisition of VitalConnect and a long-term organic revenue target of approximately $1 billion for 2027.
Tickers: $IRTC
Topics: adjusted EBITDA GAAP net loss gross margin improvement revenue growth Zio Monitor performance